93 Results (Page 1 of 8)
Singapore Markets Research Reports
Singapore Diabetes Devices Market Analysis
The Singapore Diabetes Devices Market is expected to witness growth from $27 Mn in 2022 to $50 Mn in 2030 with a CAGR of 7.80% for the forecasted year 2022-2030. An increase in the number of cases of diabetes, a shift in urbanization, and an increase in sedentary lifestyles are the main factors propelling the Singapore diabetes devices market. The market is segmented by type and by the end user. Some key players in this market include Everlife, Forefront Medical Technology, KroniKare, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Singapore Cardiac Surgery Instruments Market Analysis
The Singapore Cardiac Surgery Instruments Market is expected to witness growth from $2 Mn in 2022 to $4 Mn in 2030 with a CAGR of 7.20% for the forecasted year 2022-2030. Cardiovascular conditions such as coronary artery disease, heart failure, and arrhythmias are becoming more prevalent in Singapore due to factors such as the ageing population, sedentary lifestyles, and unhealthy diets. As a result, there is now greater demand for the tools and techniques used in heart surgery. The market is segmented by type, application and by end user. Some key players in this market include Biosensors International, Inzign Pte, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Singapore Artificial Intelligence (AI) in Healthcare Market Analysis
The Singapore Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.01 Bn in 2022 to $0.17 Bn by 2030, registering a CAGR of 45.82% during the forecast period of 2022 - 2030. The market will be driven by the need for improved efficiency, quality, and accessibility of healthcare services along with Singapore’s thriving startup ecosystem. The market is segmented by healthcare components & by healthcare applications. Some of the major players include NVIDIA, Ping An Healthcare and Technology & CoNEX Healthcare Pte Ltd.
Singapore Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Singapore Liver Disease Therapeutics market will reach a value of $45 Mn from $28 Mn in 2022, growing at a CAGR of 6.3% during 2022-2030. Liver Disease Therapeutics in Singapore is dominated by a few domestic pharmaceutical companies such as Gastro-Enterology & Education, Pharmaforte, and AsiaPharm. The Liver Disease Therapeutics market in Singapore is segmented into different types of disease and different therapy types. Some of the major factors affecting the Singapore Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Singapore Anti Aging Therapeutics Market Analysis
Singapore anti-aging therapeutics market is projected to grow from $1 Mn in 2022 to $3 Mn in 2030 with a CAGR of 17.13% for the year 2022-2030. The rising geriatric population and supportive government policies in Singapore are driving the expansion of the market. The Singapore anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key competitors in the market are Coformula, UpperMed, and Shiseido.
Singapore Biomaterials in Healthcare Market Analysis
The Singapore Biomaterials in Healthcare Market is expected to witness growth from $188 Mn in 2022 to $527 Mn in 2030 with a CAGR of 13.80% for the forecasted year 2022-2030. Tissue engineering and other regenerative therapies that depend on biomaterials are becoming more widely known and used in Singapore, which has led to an expansion of the country's Biomaterials in Healthcare market. The market is segmented by type and by application. Some key players in this market include: Biosensors International, Everlife, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Singapore ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Singapore's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $35 Mn in 2022 to $66 Mn in 2030 with a CAGR of 8.1% for the year 2022-30. The increasing demand for ADHD therapeutics and supportive government initiatives taken by Singapore are the major factors driving the growth of the market. The Singapore ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the key players in the market are Ziwell Medical, Moleac, and Alcobra.
Singapore Healthcare Insurance Market Analysis
The Singapore healthcare insurance market is projected to grow from $2.43 Bn in 2022 to $4.57 Bn by 2030, registering a CAGR of 8.2% during the forecast period of 2022 - 2030. The main factors driving the growth would be a strong economy, government support, technological advancements and an ageing population. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include NTUC Income, Great Eastern, AIA, AXA and Prudential.
Singapore 3D Printing Medical Devices Market Analysis
Singapore 3D Printing Medical Device Market is expected to witness growth from $4 Mn in 2022 to $12 Mn in 2030 with a CAGR of 16.90% for the forecasted year 2022-2030. In Singapore, the demand for 3D Printing Medical devices is being driven by Singapore's ageing population. The market is segmented by application, by technology and by end user. Some key players in this market include: Creatz3D, GE Healthcare, Stryker, Medtronic, Structo and Siemens Healthineers.
Singapore Healthcare Claims Management Market Analysis
The Singapore healthcare claims management market is projected to grow from $32.04 Mn in 2022 to $179.09 Mn by 2030, registering a CAGR of 24% during the forecast period of 2022 - 2030. The main factors driving the growth would be growing awareness, technological advancements and government initiatives. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Fullerton Health, Igloo, Fermion, Accenture and Optum.
Singapore Oncology Drugs Market Analysis
The Singapore oncology market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. The market has been increasing over the past few decades, with the highest incidence rates. The market is segmented by drug class, therapy, indication, dosage form, and distribution channel. The key companies in the Singapore oncology drugs market are AstraZeneca, Raffles Medical Group, Wave Life Sciences, Sphaera Pharma, MSD Singapore, and others.
Singapore Oncology Clinical Trials Market Analysis
Singapore's oncology clinical trials market is projected to grow from $15.2 Mn in 2022 to $24.4 Mn by 2030, registering a CAGR of 6.1% during the forecast period of 2022-30. The market will be driven by the rising number of cancer cases and a favorable regulatory climate for clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & Aslan Pharmaceuticals.
Singapore Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Singapore Liver Cancer Therapeutics market will reach a value of $13.4 Mn from $3.52 Mn in 2022, growing at a CAGR of 18.2 % during 2022-2030. The Liver Cancer Therapeutics in Singapore is dominated by a few domestic pharmaceutical companies such as Clearbridge BioMedics, A*STAR and ASLAN Pharmaceuticals. The Liver Cancer Therapeutics market in Singapore is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Singapore Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Singapore Connected Healthcare Market Analysis
The Singapore-connected healthcare market is projected to grow from $79.63 Mn in 2022 to $610.67 Mn by 2030, registering a CAGR of 29% during the forecast period of 2022 - 2030. The main factors driving the growth would be a growing ageing population, technologically advanced infrastructure, growing start-up ecosystem and government support. The market is segmented by type, function and by application. Some of the major players include Doctor Anywhere, KroniKare, HiDoc, Siemens Healthineer, Philips Healthcare and Apple.
Singapore Neurology Clinical Trials Market Analysis
The Singapore Neurology Clinical Trials market is projected to grow from $6.28 Mn in 2022 to $10.08 Mn by 2030, registering a CAGR of 6.1% during the forecast period of 2022 - 2030. The market will be driven by investments in clinical research and fostering collaborations between researchers, healthcare professionals, and industry partners. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, Biogen & Invitrocue Pte Ltd.
Singapore Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Singapore infectious disease therapeutics market will reach a value of $211.71 Mn from $143.84 Mn in 2022, growing at a CAGR of 5% during 2022-2030. The Infectious Disease Therapeutics in Singapore is dominated by a few domestic pharmaceutical companies such as A*STAR Institute, Temasek Life Sciences Laboratory and Acumen Research Laboratories. The Infectious Disease Therapeutics market in Singapore is segmented into different therapeutic areas and different diseases type. The major factors affecting the Singapore infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of Singapore.
Singapore Artificial Intelligence (AI) in Diagnostics Market Analysis
The Singapore Artificial Intelligence (AI) in the diagnostics market is projected to grow from $1.2 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by increasing demand for healthcare services such as AI diagnostics to improve patient outcomes and the government's support for AI research and development. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Claritas HealthTech.
Singapore Patient Engagement Solutions Market Analysis
The Singapore patient engagement solutions market is projected to grow from $20.41 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, technological advancements and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Holmusk, Juvoxa, Allscripts, Cerner and IBM.
Singapore Neurology Devices Market Analysis
The Singapore Neurology Devices Market size was valued at $15 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The rising demand for minimally invasive procedures, the rise in disposable income, the expansion of the healthcare system, and the development of cutting-edge technology are all factors driving the market growth for Singapore neurology devices. The market is segmented by product type and by the end user. Some key players in this market include Medtronic, Abbott Laboratories, Optima Medical, Natus Medical, and Nihon Kohden.
Singapore 3D Imaging Market Analysis
The Singapore 3D Imaging market is projected to grow from $0.04 Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022 - 2030. The market will be driven by a well-developed healthcare system and a strong emphasis on medical research and innovation. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.
Singapore HIV Therapeutics Market Analysis
By 2030, it is anticipated that the Singapore HIV therapeutics market will reach a value of $xx Mn from $16.51 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Invida Group, Tanax Pharmaceuticals, and Aslan Pharmaceuticals. The market is driven by cutting-edge healthcare infrastructure, the prevalence of HIV infections, and treatment for HIV. The HIV therapeutics market in Singapore is segmented by type, product, and geography, end user, and distribution channel.
Singapore Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Singapore Dermatology drugs market will reach a value of $xx Mn from $20.4 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as GreenCare Pharmaceuticals, Sawkare, and Kim Han Laboratories. The market is driven by Tele-dermatology, awareness about dermatological health, and the availability of generic drugs. The dermatology drug market in Singapore is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Singapore Palliative Care Market Analysis
The Singapore Palliative care market is projected to grow from $15.7 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be increased awareness, improved access to care, aging population, technological advancements, and government support. The market is segmented by service type and by the end user. Some of the major players include HCA Hospice, Homage, Red Crowns, Econ Healthcare, and Home Instead.
Singapore Cancer Pain Management Market Analysis
The Singapore Cancer Pain Management market is projected to grow from $7.82 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The main factors driving the growth would be a robust healthcare system and increasing cancer cases. The market is segmented by drug type and by disease. Some of the major players include iX Biopharma (SGP), Medtronic, Hisamitsu Pharmaceutical, Mundipharma, Pfizer, Teva Pharmaceuticals, Abbott, and Sanofi.
Singapore Nutritional Supplements Market Analysis
By 2030, it is anticipated that the Singapore Nutrition and Supplements market will reach a value of $xx Mn from $458 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The market is primarily dominated by local players such as Eu Yan Sang International, Bio-Life Science Group, and Blackmores. The market for nutrition and supplements in Singapore is primarily driven by government initiatives and increasing consumer awareness of health and lifestyle. The Singapore nutrition and supplements market in Singapore is segmented by Type, Product, application, and Distribution Channel.